Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Relative Risk01:12

Relative Risk

1.7K
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
1.7K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

380
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
380
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

468
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
468
Cancer Survival Analysis01:21

Cancer Survival Analysis

629
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
629
Statistical Methods for Analyzing Epidemiological Data01:25

Statistical Methods for Analyzing Epidemiological Data

864
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
864
Hazard Ratio01:12

Hazard Ratio

549
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
549

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Estimating the burden of leptospirosis in the Caribbean: Insights from environmental and sociodemographic factors.

PLoS neglected tropical diseases·2026
Same author

Evaluating a structured expert elicitation approach for adaptive conservation management based on lessons from five years in practice.

Conservation biology : the journal of the Society for Conservation Biology·2026
Same author

Utility of antifilarial antibodies for post-validation surveillance of lymphatic filariasis in Tonga.

Scientific reports·2026
Same author

What leads to a public health emergency of international concern? A comparison of the 2026 Ebola and hantavirus outbreaks.

Journal of travel medicine·2026
Same author

Multi-pathogen serosurveillance in Tonga examining demographic correlates and geographic clustering of 17 pathogens.

Scientific reports·2026
Same author

Integrated surveillance for lymphatic filariasis and other infectious diseases with a nationwide non-communicable disease STEPwise survey in the small Pacific Island Nation of Niue, 2025.

Scientific reports·2026

Related Experiment Video

Updated: Jan 8, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Estimating risk of long COVID using a Bayesian network-based decision support tool.

Jane E Sinclair1, Helen J Mayfield2, Hongen Lu3

  • 1School of Chemistry and Molecular Biosciences, The University of Queensland, Australia.

Vaccine
|December 19, 2025
PubMed
Summary

Vaccination, early drug treatment, and avoiding reinfection significantly reduce long COVID risk. A new tool helps individuals assess and manage their personal risk factors for long COVID.

Keywords:
ComorbidityLong COVIDPASCRisk factorsSARS-CoV-2Vaccines

More Related Videos

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Related Experiment Videos

Last Updated: Jan 8, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

2.2K

Area of Science:

  • Epidemiology and Public Health
  • Infectious Disease Modeling
  • Health Informatics

Background:

  • Long COVID poses a significant global health burden, affecting over 30% of adults post-symptomatic COVID-19.
  • Accessible information on vaccines and treatments is crucial for individuals at risk of long COVID.

Purpose of the Study:

  • Quantify modifiable risk factors for developing long COVID six months post-infection.
  • Develop a decision support tool for managing these risk factors.

Main Methods:

  • A Bayesian network model was developed using data from published studies and government reports.
  • The model estimates long COVID probability based on demographics, comorbidities, vaccination history, prior infections, and acute infection treatments.
  • Outcome measures include acute infection severity and long COVID risk, including specific persistent symptoms.

Main Results:

  • Vaccination, early drug treatment (within 3 days), and avoiding reinfection are key modifiable factors reducing long COVID risk by up to 63%.
  • An interactive web-based decision support tool is available to calculate personalized long COVID probabilities.
  • The tool allows users to explore different scenarios of modifiable risk factors.

Conclusions:

  • The decision-support tool facilitates shared decision-making between individuals and clinicians regarding vaccination and early treatment.
  • It supports informed choices on protective behaviors like masking and social distancing.
  • The model provides population-level insights for public health policy development.